| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.25 | 3e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.2 | 7e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |